NEW YORK (GenomeWeb) – CombiMatrix today reported a 37 percent increase in second quarter revenues, driven by higher test volumes in its reproductive health and pediatric segments as well as improved test reimbursement across all segments.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.
This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.